CA1155578A - Thermoplastic elastomeric block copolymer balloon-type catheters - Google Patents
Thermoplastic elastomeric block copolymer balloon-type cathetersInfo
- Publication number
- CA1155578A CA1155578A CA000316346A CA316346A CA1155578A CA 1155578 A CA1155578 A CA 1155578A CA 000316346 A CA000316346 A CA 000316346A CA 316346 A CA316346 A CA 316346A CA 1155578 A CA1155578 A CA 1155578A
- Authority
- CA
- Canada
- Prior art keywords
- catheter
- balloon
- weight
- shaft
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/049—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/141—Plasticizers
Abstract
IMPROVED BALLOON-TYPE CATHETER
Inventors: Lawrence F. Becker John J. Donohue Dean G. Laurin Henry M. Gajewski ABSTRACT OF THE DISCLOSURE
A balloon-type catheter is disclosed having a catheter shank made of a block copolymer having thermo-plastic rubber characteristics with a central block of ethylene-butylene copolymer and terminal blocks of poly-styrene. The inflatable balloon member, and preferably the distal Y-member, of the catheter are made of an elas-tic composition which includes the same or a similar block copolymer, in the presence of polystyrene or equi-valent material as a tackifying agent, polypropylene, and an oil-type plasticizer.
Inventors: Lawrence F. Becker John J. Donohue Dean G. Laurin Henry M. Gajewski ABSTRACT OF THE DISCLOSURE
A balloon-type catheter is disclosed having a catheter shank made of a block copolymer having thermo-plastic rubber characteristics with a central block of ethylene-butylene copolymer and terminal blocks of poly-styrene. The inflatable balloon member, and preferably the distal Y-member, of the catheter are made of an elas-tic composition which includes the same or a similar block copolymer, in the presence of polystyrene or equi-valent material as a tackifying agent, polypropylene, and an oil-type plasticizer.
Description
S~78 BACKGROUND OF THE INVENTION
Balloon catheters are commonly used, particu-larly the Foley catheter which finds major use in urinary ~ract surgery. The catheter is inserted into the urethra until the catheter head extends into the bladder. Then a - balloon adjacent the head is inflated to retain the catheter for usually a period of days. However, a catheter may be inserted for an indefinite period of time in chronic situations.
The early designs of balloon catheters were made of natural rubber latex. As is known, the latex causes a reaction in the tissues which are adjacent to it, which can be quite uncomfortable for the patient, and which is medically undesirable.
In more recent times, balloon catheters have been fabricated out of silicone rubber, or out of latex which is coated with a film of silicone rubber, to avoid the tissue reaction problem. However, these catheters are considerably more expensive than the latex catheters, and they share with the latex catheters the disadvantage that they are somewhat difficult to fabricate, because both latex and silicone rubber are generally not thermoplastic materials, and thus must be cured over a period of time in order to obtain the desired physical properties.
Another type of balloon catheter has a polyvinyl chloride tubular shank, attached to a natural rubber
Balloon catheters are commonly used, particu-larly the Foley catheter which finds major use in urinary ~ract surgery. The catheter is inserted into the urethra until the catheter head extends into the bladder. Then a - balloon adjacent the head is inflated to retain the catheter for usually a period of days. However, a catheter may be inserted for an indefinite period of time in chronic situations.
The early designs of balloon catheters were made of natural rubber latex. As is known, the latex causes a reaction in the tissues which are adjacent to it, which can be quite uncomfortable for the patient, and which is medically undesirable.
In more recent times, balloon catheters have been fabricated out of silicone rubber, or out of latex which is coated with a film of silicone rubber, to avoid the tissue reaction problem. However, these catheters are considerably more expensive than the latex catheters, and they share with the latex catheters the disadvantage that they are somewhat difficult to fabricate, because both latex and silicone rubber are generally not thermoplastic materials, and thus must be cured over a period of time in order to obtain the desired physical properties.
Another type of balloon catheter has a polyvinyl chloride tubular shank, attached to a natural rubber
-2-1 1 5~578 latex balloon, because of the unsuitability of vinyl as a balloon material. Thus, ~he latex balloon remains as an irritant. Also, vinyl catheters have exhibited an un-desirable "feel" to the patient.
In accordance with this invention, a new catheter is provided which can exhibit an extremely low toxicity so that little or no irritation is felt by the patient.
The balloon of the catheter of this invention exhibits particularly good elastomeric recovery, with low creep, so that there is little "pruning" upon deflation of the balloon, i.e. the formation of wrinkles in the balloon.
While the material of the catheter of this inven-tion, on a cost basis, is similar to natural rubber latex and the like, it is as non-toxic as silicone rubber, there-by combining the advantages of the two types of catheters.
Also, as a further advantage, the tubular shaft of the catheter of this invention may be formed by simple extrusion, without a post cure time, since the material of the catheter may be thermoplastic, but also of a softening temperature which permits autoclaving of the catheter if desired.
Also, parts of the catheter may be thermoformed or injection molded as desired. The tubing of the catheter of this invention may be kink and collapse resis-tant upon aspiration and normal use, and it may be fabri-cated by heat sealing, without separate adhesives.
~ ~557~
~lso, the cost of fabrica-tion of the ca-the-ters of -this inven-tion may be further reduced by the fact that scrap materia]s Erom the production of the catheter may be reused in molding or extrusion, since the material is of thermoplastic rather than of the thermoset type.
The catheters oE this invention are also stable under radiation sterili~ation.
According to the present invention there is provided a balloon-type catheter which comprises a tubular shaft and an inflatable reter~tion balloon member sealed in position on the shaft at the distal end~ the shaft and balloon members being made of a thermoplastic elastic composition which comprises a block copolymer formed of a central rubbery polyolefin block comprising an ethylene-butylene copolymer and thermoplastic polystyrene end blocks mixed with sufficient hydrophobic oil-type plasticiser to provide the desired degree of softness ! to the elastic composition.
More specifically, the present invention provides a balloon-type catheter which includes a tubular shaft and an inflatable balloon member, carried by the catheter, the shaft and balloon member being made of an elastic composition which includes a block of copolymer having thermoplastic rubber characteristics with a central rubber polyolefin block including an ethylPne-butylene copolymer and terminal blocks of polystyrene. The block copolymer exhibits a BrookEield viscosity of 25 degrees C. of 10 to 2000 cps, when measured using a 10 percent by weight solids solution in toluene. The composition optionall~ includes from 0 to 45 percent by weight of polypropylene, the formulation being mixed with sufficient hydrophobic oil-type plasticizer to provide the desired degree of softness to the elastic co~position, the balloon member being sealed in position on the shaft.
sb/~
In a speci ric embo~imerlt Or the invention, at least one of the shaft and balloon members contains from 5 to 30 percent by weight of a tacking agent which comprises a low molecula~- polystyrene.
However, if the molecular weight of the block copolymer formulations is of an average of about 80,000 or less an adhesive or tackifying agent may not be needed to seal the parts together. Specifically, the block copolymers having thermoplastic rubber characteristics described above are commercially available under the trademark KRATON from the Shell Chemical Company, or SOLPRENE from the Phillips Petroleum Company. Other rubbery block copolymers which are available under these trademarks utilize a central block including butadiene or isoprene, rather than the ethylene butylene copolymer units preferably utilized herein. These substitute materials may be contemplated for use as equivalents to the ethylene-butylene copolymer block.
Mixtures of the above-described block copolymers of different molecular weight also may be desirable for use.
An advantage of such mixtures is that a component of the mixture may include the block copolymer as described above with a molecular weight which is in itself too high to permit extrusion, with the extrudability being facilitated by a component of lower molecular weight block copolymer, to obtain an advantage in physical properties from the high molecular weight component (for example, a solution visco-pc/,~f 1 :lS~78 sity as calculated above of 1000 cps. The lower molecu-lar weight components of the block copolymer described above may preferably have similar solution viscosities on the order of 20 to 100 cps.
Preferably, in the block copolymers described above, the central block of ethylene-butylene units may comprise 50 to 85 percent by weight of the copolymer mole-cule, while the terminal blocks of polystyrene or e~uiva-lent mat~rial comprise the balance of the compound.
This formulation used herein may also contain a titanium dioxide pigment or the like, for appropriate colo-ration of the catheter, as well as other desired additives such as stabilizing agents, plasticizers such as mineral oil, and flow aid and hardener materials such as polypro-pylene.
Typically, a molded, branched connector such as a Y-site is attached at the distal end of the tubular shaft of the catheter. The branched connector may also be made of the elastic composition described above.
Either or both of the shaft and the balloon member (and the branched connector when used) desirably may con-tain from 5 to 30 percent by weight of tackifying agent such as low molecular weight polystyrene. When at least one of the formulations contains this material, it facili-tates the adhesion of the balloon member and the Y-connector to the catheter shaft without the use of adhesive by heat sealing or molding the balloon member and connector in place 1 15~8 on the shaft. The polystyrene material used may preferably be of a molecular weight, for example, of 1000 to 6000, as a tackifier.
Preferably up to 30 percent of the polypropylene may be used in the oil-extended compound, both as a flow aid and as a surface finish, depending on the molecular weight of the polypropylene. Generally, more polypropylene is needed as a flow or extrusion aid when the block copolymers used in this invention are of higher molecular weight. In particular, from about one to Eive weight percent of polypropylene having a melt flow of zbout 50 to 100, as tested under ASTM D1238-70, provides an improved, smooth surface finish. Also, crystalline polypropylene is believed to act as a diffusion barrier.
In the ~rawings, Figure 1 is a plan view of a typical Foley catheter which may be manulactured in accordance with this invention.
Figure 2 is a detailed view of the catheter of Figure 1, taken partly in section, showing the catheter balloon member adhered to the catheter shaft.
R,eferring to the drawings, the catheter of this invention is shown defining a double lumen tubular shaft 10 which may be extruded to define a drainage lumen 12 and an inflation lumen 14 in accordance with conventional technology. Tip member 16 may be conventionally thermo-formed on the catheter so that drainage lumen 12 communicates through aperture 18 to the exterior, and inflation lumen 14 is closed off.
Aperture 20 is provided in the wall of shaft 10 to provide communi-cation between the inElation lumen 14 and the exterior of shaft 10. Balloon 22, being a thin-walled tube, is sealed, for example by a non-contact radi-5 ~1 8 ant heat source, at ends 24 to the outer wall of shaft 10 about aperture 20. Accordingly, when pressurized air or liquid is provided to inflate lumen ~4, balloon 22 will expand.
Branched or Y-connector 26 comprises a pair of branching channels~ Channel 28 is adapted to receive a pressure syringe, and communicates with the inflation lu-men 14. Valve 30 is provided to receive the luer of a syringe and to allow it to pass to place pressurized fluid into the inflation lumen 14. Valve 30 is also adapted to retain that pressure when the syringe is withdrawn, and may be of conventional construction for a Foley catheter.
Branched tube 32 is adapted to communicate with the cathe-ter adapter of a urinary drainage bag or the like at its outer end 34, and communicates with drainage lumen 12 within catheter shaft 10.
The following examples are provided to illustrate specific examples of formulations which may be utilized in the catheter of this invention. These specific examples are for illustrative purposes only, and are not intended to limit the scope of the invention of this application, which is as defined in the claims below.
Example 1. A material for formulating extruded shaft 10 of the catheter of this invention was prepared by mixing the following ingredients in a ribbon blender:
100 parts by weight of a block copolymer of ethylene butylene copolymer having terminal blocks of polystyrene (known as Kraton G1651--Brookfield viscosity as a 10 weight 1 155~78 percent solution in toluene at 25 C.--lOQO cps.; weight percent of the central block: 67 percent); and 40 parts by weight of polypropylene havi~ng a melt flow of 5 (ASTM
D1~38--70; *Shell 5520). To this mixture was added 100 parts by weight of U.S.P. light grade whi.te mineral oil, manufactured by Wi-tco Chemical Company, Sonneborn Divisionl New York, New York; (viscosity at 100 degrees F. of 350 Saybolt seconds) as a plasticizer. To this formulation was also added about 0.03 to 0.07 percent by weight of an equal weight mixture of 10 two stabilizers, one commercially available~ Tetrakis~methylene
In accordance with this invention, a new catheter is provided which can exhibit an extremely low toxicity so that little or no irritation is felt by the patient.
The balloon of the catheter of this invention exhibits particularly good elastomeric recovery, with low creep, so that there is little "pruning" upon deflation of the balloon, i.e. the formation of wrinkles in the balloon.
While the material of the catheter of this inven-tion, on a cost basis, is similar to natural rubber latex and the like, it is as non-toxic as silicone rubber, there-by combining the advantages of the two types of catheters.
Also, as a further advantage, the tubular shaft of the catheter of this invention may be formed by simple extrusion, without a post cure time, since the material of the catheter may be thermoplastic, but also of a softening temperature which permits autoclaving of the catheter if desired.
Also, parts of the catheter may be thermoformed or injection molded as desired. The tubing of the catheter of this invention may be kink and collapse resis-tant upon aspiration and normal use, and it may be fabri-cated by heat sealing, without separate adhesives.
~ ~557~
~lso, the cost of fabrica-tion of the ca-the-ters of -this inven-tion may be further reduced by the fact that scrap materia]s Erom the production of the catheter may be reused in molding or extrusion, since the material is of thermoplastic rather than of the thermoset type.
The catheters oE this invention are also stable under radiation sterili~ation.
According to the present invention there is provided a balloon-type catheter which comprises a tubular shaft and an inflatable reter~tion balloon member sealed in position on the shaft at the distal end~ the shaft and balloon members being made of a thermoplastic elastic composition which comprises a block copolymer formed of a central rubbery polyolefin block comprising an ethylene-butylene copolymer and thermoplastic polystyrene end blocks mixed with sufficient hydrophobic oil-type plasticiser to provide the desired degree of softness ! to the elastic composition.
More specifically, the present invention provides a balloon-type catheter which includes a tubular shaft and an inflatable balloon member, carried by the catheter, the shaft and balloon member being made of an elastic composition which includes a block of copolymer having thermoplastic rubber characteristics with a central rubber polyolefin block including an ethylPne-butylene copolymer and terminal blocks of polystyrene. The block copolymer exhibits a BrookEield viscosity of 25 degrees C. of 10 to 2000 cps, when measured using a 10 percent by weight solids solution in toluene. The composition optionall~ includes from 0 to 45 percent by weight of polypropylene, the formulation being mixed with sufficient hydrophobic oil-type plasticizer to provide the desired degree of softness to the elastic co~position, the balloon member being sealed in position on the shaft.
sb/~
In a speci ric embo~imerlt Or the invention, at least one of the shaft and balloon members contains from 5 to 30 percent by weight of a tacking agent which comprises a low molecula~- polystyrene.
However, if the molecular weight of the block copolymer formulations is of an average of about 80,000 or less an adhesive or tackifying agent may not be needed to seal the parts together. Specifically, the block copolymers having thermoplastic rubber characteristics described above are commercially available under the trademark KRATON from the Shell Chemical Company, or SOLPRENE from the Phillips Petroleum Company. Other rubbery block copolymers which are available under these trademarks utilize a central block including butadiene or isoprene, rather than the ethylene butylene copolymer units preferably utilized herein. These substitute materials may be contemplated for use as equivalents to the ethylene-butylene copolymer block.
Mixtures of the above-described block copolymers of different molecular weight also may be desirable for use.
An advantage of such mixtures is that a component of the mixture may include the block copolymer as described above with a molecular weight which is in itself too high to permit extrusion, with the extrudability being facilitated by a component of lower molecular weight block copolymer, to obtain an advantage in physical properties from the high molecular weight component (for example, a solution visco-pc/,~f 1 :lS~78 sity as calculated above of 1000 cps. The lower molecu-lar weight components of the block copolymer described above may preferably have similar solution viscosities on the order of 20 to 100 cps.
Preferably, in the block copolymers described above, the central block of ethylene-butylene units may comprise 50 to 85 percent by weight of the copolymer mole-cule, while the terminal blocks of polystyrene or e~uiva-lent mat~rial comprise the balance of the compound.
This formulation used herein may also contain a titanium dioxide pigment or the like, for appropriate colo-ration of the catheter, as well as other desired additives such as stabilizing agents, plasticizers such as mineral oil, and flow aid and hardener materials such as polypro-pylene.
Typically, a molded, branched connector such as a Y-site is attached at the distal end of the tubular shaft of the catheter. The branched connector may also be made of the elastic composition described above.
Either or both of the shaft and the balloon member (and the branched connector when used) desirably may con-tain from 5 to 30 percent by weight of tackifying agent such as low molecular weight polystyrene. When at least one of the formulations contains this material, it facili-tates the adhesion of the balloon member and the Y-connector to the catheter shaft without the use of adhesive by heat sealing or molding the balloon member and connector in place 1 15~8 on the shaft. The polystyrene material used may preferably be of a molecular weight, for example, of 1000 to 6000, as a tackifier.
Preferably up to 30 percent of the polypropylene may be used in the oil-extended compound, both as a flow aid and as a surface finish, depending on the molecular weight of the polypropylene. Generally, more polypropylene is needed as a flow or extrusion aid when the block copolymers used in this invention are of higher molecular weight. In particular, from about one to Eive weight percent of polypropylene having a melt flow of zbout 50 to 100, as tested under ASTM D1238-70, provides an improved, smooth surface finish. Also, crystalline polypropylene is believed to act as a diffusion barrier.
In the ~rawings, Figure 1 is a plan view of a typical Foley catheter which may be manulactured in accordance with this invention.
Figure 2 is a detailed view of the catheter of Figure 1, taken partly in section, showing the catheter balloon member adhered to the catheter shaft.
R,eferring to the drawings, the catheter of this invention is shown defining a double lumen tubular shaft 10 which may be extruded to define a drainage lumen 12 and an inflation lumen 14 in accordance with conventional technology. Tip member 16 may be conventionally thermo-formed on the catheter so that drainage lumen 12 communicates through aperture 18 to the exterior, and inflation lumen 14 is closed off.
Aperture 20 is provided in the wall of shaft 10 to provide communi-cation between the inElation lumen 14 and the exterior of shaft 10. Balloon 22, being a thin-walled tube, is sealed, for example by a non-contact radi-5 ~1 8 ant heat source, at ends 24 to the outer wall of shaft 10 about aperture 20. Accordingly, when pressurized air or liquid is provided to inflate lumen ~4, balloon 22 will expand.
Branched or Y-connector 26 comprises a pair of branching channels~ Channel 28 is adapted to receive a pressure syringe, and communicates with the inflation lu-men 14. Valve 30 is provided to receive the luer of a syringe and to allow it to pass to place pressurized fluid into the inflation lumen 14. Valve 30 is also adapted to retain that pressure when the syringe is withdrawn, and may be of conventional construction for a Foley catheter.
Branched tube 32 is adapted to communicate with the cathe-ter adapter of a urinary drainage bag or the like at its outer end 34, and communicates with drainage lumen 12 within catheter shaft 10.
The following examples are provided to illustrate specific examples of formulations which may be utilized in the catheter of this invention. These specific examples are for illustrative purposes only, and are not intended to limit the scope of the invention of this application, which is as defined in the claims below.
Example 1. A material for formulating extruded shaft 10 of the catheter of this invention was prepared by mixing the following ingredients in a ribbon blender:
100 parts by weight of a block copolymer of ethylene butylene copolymer having terminal blocks of polystyrene (known as Kraton G1651--Brookfield viscosity as a 10 weight 1 155~78 percent solution in toluene at 25 C.--lOQO cps.; weight percent of the central block: 67 percent); and 40 parts by weight of polypropylene havi~ng a melt flow of 5 (ASTM
D1~38--70; *Shell 5520). To this mixture was added 100 parts by weight of U.S.P. light grade whi.te mineral oil, manufactured by Wi-tco Chemical Company, Sonneborn Divisionl New York, New York; (viscosity at 100 degrees F. of 350 Saybolt seconds) as a plasticizer. To this formulation was also added about 0.03 to 0.07 percent by weight of an equal weight mixture of 10 two stabilizers, one commercially available~ Tetrakis~methylene
3-(3',5'-di-t-butyl-4'hydroxyphenyl) propionate~ methane, under the trademark Ir~anox 1010 ~y the Ciba-Geigy Companyr and the other being dilauryl-thiodipropionate.
One hundred parts by weight of the followlng formulation were blended with one part by weight of a titanium dioxide pigment (*Ti-Pure R-221, manufactured by E. I. DuPont de Nemours¦.
After mixing o~ this formulation r it was extruded at 350-400 degrees F. in a conventional extruder to form the 2Q double lumen catheter tube 10.
For the catheter of this invention, balloon member 20 was extruded and Y-connector 26 was conventionally molded out of a formula~ti.on containing the following ingredients:
(a) 65 percent by weight of a mixture of 100 parts by weight of the block copolymer described immediately above (*Kraton G1651¦ and 85 parts by weight of the mineral oil described abovei *trade m~rk ~' 9 -/t~
~ ~$5~8 (b) 17 percent by weight of a mixture comprising 100 parts by weight of an ethylene butylene block copoly-mer with polystyrene end blocks of lower molecular weight (~aton G1650; Brookfield viscosity as a 10 percent toluene solution--60 cps. at 25 degrees C.; weight percent of the ethylene-butylene block: 70 percent); 51 parts vf polypro-pylene having a melt flow of 12 according to ASTM D1238-70 ~*Shell 5820); 19 parts by weight of a copolymer of alphamethyl styrene and vinyl toluene (~iccotex 120, sold by Hercules Chemical Company); and 100 parts by weight of the mineral oil described previously.
(c) 15 percent by weight of a low molecular weight polystyrene having a ring and ball softening point of about 100 degrees C. (*Piccolastic E100, sold by Hercules L5 Chemical Company).
(d) 3 percent by weight of a high melting poly-propylene ~*Tenite 4G7DP sold by Eastman Chemical Products, IncO) having a melt flow of 60 according to ASTM D1238-70), as a surface finish improving agent.
To one hundred parts by weight of the above formulation was added one part of the titanium dioxide pigment described above. The mixture was thorougly mixed in a ribbon blender; the balloon 22 was heat sealed in position on shaft 10, while Y-connector 26 was molded on the catheter~ both without adhesive. Tip 16 is thermo-*Trade marks ~ 1 S~57$
formed.
The formulation also contains from 0.03 to 0.07 - percent by weight of the stabilizers described earlier.
Example 2. Another catheter may be pxepared by extruding shaft 10 out of a formulation of the following composition:
A. 60 percent by weight of a mixture of 100 parts by weight of Rraton G1651 (described above) and 85 parts by weight of the mineral oil described above.
B. 5 percent by weight o~ polypropylene having a melt ~low of 60 under the test described above ~Tenite 4G7DP).
C. 10 percent by weight of the low mol.ecular weight polystyrene described above (Piccolastic E100).
D. 5 percent by weight of polypropylene having a melt flow of approximately 2 according to ASTM D-123B
(condition L).
E. 20 percent by weight of the mineral oil described above.
One hundred parts of this formulation were mixed with two parts of the titanium dioxide pigment described in Example 1, and blended for extrusion at 350 degrees to 400 degrees F. into the double lumen shaft 10 of the catheter of this invention.
The balloon 22 may, in this instance, be extruded l 15~5~
from a formulation of the block copolymer of ethylene-butylene with polystyrene end blocks, in which the ethylene-but~lene portion of the copolymer comprises about 70 percent by weight o the copolymer molecule, haviny a Brookfield viscosity at 25 degrees C. of 20 cps. using a 10 weight percent solution in toluene, and containing from 0.03 to 0~07 per cent by weight of A0330 antioxidant (*KratonG1662). To this is added 40 percent by weight of the mineral oil described in Example 1 above.
The composition is then blended.
One hundred parts by weight of this blended formulation was then mixed with two parts by weight of the titanium dioxide pigment. Balloon 22 is made from this formulation, and may be directly molded about and in contact with shaft 10.
Y-connector site 26 may be formulated out of the same material as it was formulated from in the previous example.
The distal end of catheter shaft 10 is inserted into an injection mold for Y-site 26, with the Y-site being then molded about the distal end, with good adhe-sion taking place between the molded Y-connector 26 and shaft 10 of the catheter without the need for an adhesive.
Valve 30 is then inserted into the Y-site to complete the construction of the catheter which exhibits *Trade mark 1 15~5'~
the advantages described previously.
~ e~ In this example, shaft 10 for a catheter was made from a formulation comprising 100 parts by weight of the following ingredients:
~a) 30 percent by weight of the block copoly-mer material utilized in the balloon formulation in Example 2 (Kxaton 1662).
(b) 20 percent by weight of the poly(ethylene-butylene)-polystyrene copolymer of Example l(b), and further containing an effective level of the Exampl~ 1.
antioxidant described previously (Kraton G1650).
(c) 5 percent of the polypropylene formulation having a melt flow of 60 as described in Example 2.
(d) 5 percent by weight of a polypropylene ma-terial having a melt flow of about 2.
(e) 40 percent by weight of the mineral oil described in Example 1.
To 100 parts by weight of this mixture was added 2 parts by weight of the titanium dioxide pigment described previously. The mixture is processed as previously des-cribed.
It is also contempla~ed as an alternative to utilize a single type of antioxidant, either one ox the other, in conjunction with the two types of block copoly-mer.
1~S~
This material was blended and extruded in the manner of ~he previous examples to form shafts 10 of ca-theters made in accordance with this invention.
The balloon was extruded of the same material as in Example 2, and sealed on-to the shaft, after punching aperture 20. The Y-connector site material may be identi-cal to the shaft material of Example 1 and may be molded on to the shaft in the same manner as is described pre-viously.
It is noted in this Example that, because of the : relatively low average molecular weight and ~rookfield viscosity of the block copolymer utilized herein, it is not necessary to provide a low melting polystyrene to the balloon or the shaft formulations since adhesion between the mater.ials upon molding takes place spontaneously in this instance.
One hundred parts by weight of the followlng formulation were blended with one part by weight of a titanium dioxide pigment (*Ti-Pure R-221, manufactured by E. I. DuPont de Nemours¦.
After mixing o~ this formulation r it was extruded at 350-400 degrees F. in a conventional extruder to form the 2Q double lumen catheter tube 10.
For the catheter of this invention, balloon member 20 was extruded and Y-connector 26 was conventionally molded out of a formula~ti.on containing the following ingredients:
(a) 65 percent by weight of a mixture of 100 parts by weight of the block copolymer described immediately above (*Kraton G1651¦ and 85 parts by weight of the mineral oil described abovei *trade m~rk ~' 9 -/t~
~ ~$5~8 (b) 17 percent by weight of a mixture comprising 100 parts by weight of an ethylene butylene block copoly-mer with polystyrene end blocks of lower molecular weight (~aton G1650; Brookfield viscosity as a 10 percent toluene solution--60 cps. at 25 degrees C.; weight percent of the ethylene-butylene block: 70 percent); 51 parts vf polypro-pylene having a melt flow of 12 according to ASTM D1238-70 ~*Shell 5820); 19 parts by weight of a copolymer of alphamethyl styrene and vinyl toluene (~iccotex 120, sold by Hercules Chemical Company); and 100 parts by weight of the mineral oil described previously.
(c) 15 percent by weight of a low molecular weight polystyrene having a ring and ball softening point of about 100 degrees C. (*Piccolastic E100, sold by Hercules L5 Chemical Company).
(d) 3 percent by weight of a high melting poly-propylene ~*Tenite 4G7DP sold by Eastman Chemical Products, IncO) having a melt flow of 60 according to ASTM D1238-70), as a surface finish improving agent.
To one hundred parts by weight of the above formulation was added one part of the titanium dioxide pigment described above. The mixture was thorougly mixed in a ribbon blender; the balloon 22 was heat sealed in position on shaft 10, while Y-connector 26 was molded on the catheter~ both without adhesive. Tip 16 is thermo-*Trade marks ~ 1 S~57$
formed.
The formulation also contains from 0.03 to 0.07 - percent by weight of the stabilizers described earlier.
Example 2. Another catheter may be pxepared by extruding shaft 10 out of a formulation of the following composition:
A. 60 percent by weight of a mixture of 100 parts by weight of Rraton G1651 (described above) and 85 parts by weight of the mineral oil described above.
B. 5 percent by weight o~ polypropylene having a melt ~low of 60 under the test described above ~Tenite 4G7DP).
C. 10 percent by weight of the low mol.ecular weight polystyrene described above (Piccolastic E100).
D. 5 percent by weight of polypropylene having a melt flow of approximately 2 according to ASTM D-123B
(condition L).
E. 20 percent by weight of the mineral oil described above.
One hundred parts of this formulation were mixed with two parts of the titanium dioxide pigment described in Example 1, and blended for extrusion at 350 degrees to 400 degrees F. into the double lumen shaft 10 of the catheter of this invention.
The balloon 22 may, in this instance, be extruded l 15~5~
from a formulation of the block copolymer of ethylene-butylene with polystyrene end blocks, in which the ethylene-but~lene portion of the copolymer comprises about 70 percent by weight o the copolymer molecule, haviny a Brookfield viscosity at 25 degrees C. of 20 cps. using a 10 weight percent solution in toluene, and containing from 0.03 to 0~07 per cent by weight of A0330 antioxidant (*KratonG1662). To this is added 40 percent by weight of the mineral oil described in Example 1 above.
The composition is then blended.
One hundred parts by weight of this blended formulation was then mixed with two parts by weight of the titanium dioxide pigment. Balloon 22 is made from this formulation, and may be directly molded about and in contact with shaft 10.
Y-connector site 26 may be formulated out of the same material as it was formulated from in the previous example.
The distal end of catheter shaft 10 is inserted into an injection mold for Y-site 26, with the Y-site being then molded about the distal end, with good adhe-sion taking place between the molded Y-connector 26 and shaft 10 of the catheter without the need for an adhesive.
Valve 30 is then inserted into the Y-site to complete the construction of the catheter which exhibits *Trade mark 1 15~5'~
the advantages described previously.
~ e~ In this example, shaft 10 for a catheter was made from a formulation comprising 100 parts by weight of the following ingredients:
~a) 30 percent by weight of the block copoly-mer material utilized in the balloon formulation in Example 2 (Kxaton 1662).
(b) 20 percent by weight of the poly(ethylene-butylene)-polystyrene copolymer of Example l(b), and further containing an effective level of the Exampl~ 1.
antioxidant described previously (Kraton G1650).
(c) 5 percent of the polypropylene formulation having a melt flow of 60 as described in Example 2.
(d) 5 percent by weight of a polypropylene ma-terial having a melt flow of about 2.
(e) 40 percent by weight of the mineral oil described in Example 1.
To 100 parts by weight of this mixture was added 2 parts by weight of the titanium dioxide pigment described previously. The mixture is processed as previously des-cribed.
It is also contempla~ed as an alternative to utilize a single type of antioxidant, either one ox the other, in conjunction with the two types of block copoly-mer.
1~S~
This material was blended and extruded in the manner of ~he previous examples to form shafts 10 of ca-theters made in accordance with this invention.
The balloon was extruded of the same material as in Example 2, and sealed on-to the shaft, after punching aperture 20. The Y-connector site material may be identi-cal to the shaft material of Example 1 and may be molded on to the shaft in the same manner as is described pre-viously.
It is noted in this Example that, because of the : relatively low average molecular weight and ~rookfield viscosity of the block copolymer utilized herein, it is not necessary to provide a low melting polystyrene to the balloon or the shaft formulations since adhesion between the mater.ials upon molding takes place spontaneously in this instance.
Claims (8)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A balloon-type catheter which comprises a tubular shaft and an inflatable balloon member, carried by said catheter, said shaft and balloon member being made of an elastic composition which comprises: a block copolymer having thermoplastic rubber characteristics with a central rubbery polyolefin block comprising an ethylene-butylene copolymer and terminal blocks of polystyrene, said block copolymer exhibiting a Brookfield viscosity at 25 degrees C.
of 10 to 2000 cps. when measured using a 10 percent by weight solids solution in toluene, said composition optionally including from 0 to 45 percent by weight of polypropylene, said formulation being-mixed with sufficient hydrophobic oil-type plasticizer to provide the desired degree of softness to said elastic composition, said balloon member being sealed in position on said shaft.
of 10 to 2000 cps. when measured using a 10 percent by weight solids solution in toluene, said composition optionally including from 0 to 45 percent by weight of polypropylene, said formulation being-mixed with sufficient hydrophobic oil-type plasticizer to provide the desired degree of softness to said elastic composition, said balloon member being sealed in position on said shaft.
2. The balloon-type catheter of Claim 1 which carries a molded, branched connector at its distal end attached to said tubular shank, said branched connector being made of said elastic composition.
3. The balloon-type catheter of Claim 2 in which the formulation for said shaft contains from one to five percent by weight of polypropylene having a melt flow of essentially 50 to 100, as tested under ASTM D1238-70.
4. The catheter of Claim 3 which contains a titanium oxide pigment.
5. The catheter of Claim 2 in which said central rubbery polyolefin block comprises from 50 to 85 percent by weight of the copolymer molecule.
6. The catheter of Claim 1 in which at least one of said shaft and balloon member contains from 5 to 30 percent by weight of a tackifying agent which comprises a low molecular weight polystyrene.
7. A balloon-type catheter which comprises a tubular shaft and an inflatable retention balloon member sealed in position on said shaft at the distal end, said shaft and balloon members being made of a thermoplastic elastic composition which comprises a block copolymer formed of a central rubbery polyolefin block comprising an ethylene-butylene copolymer and thermoplastic polystyrene end blocks mixed with sufficient hydrophobic oil-type plasticiser to provide the desired degree of softness to said elastic composition.
8. The catheter of claim 7 wherein the composition additionally contains polypropylene as a modifying additive.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US853,738 | 1977-11-21 | ||
| US05/853,738 US4154244A (en) | 1977-11-21 | 1977-11-21 | Balloon-type catheter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1155578A true CA1155578A (en) | 1983-10-18 |
Family
ID=25316771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000316346A Expired CA1155578A (en) | 1977-11-21 | 1978-11-16 | Thermoplastic elastomeric block copolymer balloon-type catheters |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US4154244A (en) |
| CA (1) | CA1155578A (en) |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4198983A (en) * | 1978-04-28 | 1980-04-22 | Baxter Travenol Laboratories, Inc. | Catheter made of a thermoplastic material having improved softness and low friction |
| US4284459A (en) * | 1978-07-03 | 1981-08-18 | The Kendall Company | Method for making a molded catheter |
| US4251305A (en) * | 1978-11-01 | 1981-02-17 | Baxter Travenol Laboratories, Inc. | Method of radiant heat sealing of a balloon onto a catheter employing tinted shrink tubing |
| JPS57170265A (en) * | 1981-04-15 | 1982-10-20 | Hitachi Cable | Cathetel |
| US4547187A (en) * | 1983-05-06 | 1985-10-15 | Thomas R. Kelly, M.D., Inc. | Inflatable cholangiocath and method for cholangiography therewith |
| USRE32983E (en) * | 1983-07-05 | 1989-07-11 | E. I. Du Pont De Nemours And Company | Balloon and manufacture thereof |
| USRE33561E (en) * | 1983-07-05 | 1991-03-26 | E. I. Du Pont De Nemours And Company | Balloon and manufacture thereof |
| US4692200A (en) * | 1985-07-30 | 1987-09-08 | Advanced Cardiovascular Systems, Inc. | Self-venting balloon dilatation catheter and method |
| US4921483A (en) * | 1985-12-19 | 1990-05-01 | Leocor, Inc. | Angioplasty catheter |
| US4884573A (en) * | 1988-03-07 | 1989-12-05 | Leocor, Inc. | Very low profile angioplasty balloon catheter with capacity to use steerable, removable guidewire |
| US6500146B1 (en) | 1988-10-04 | 2002-12-31 | Cordis Corporation | Balloons for medical devices and fabrication thereof |
| US5304197A (en) * | 1988-10-04 | 1994-04-19 | Cordis Corporation | Balloons for medical devices and fabrication thereof |
| US5024655A (en) * | 1989-09-05 | 1991-06-18 | Freeman Andrew B | Epidural catheter apparatus and associated method |
| US5084016A (en) * | 1989-09-05 | 1992-01-28 | Freeman Andrew B | Epidural catheter apparatus with an inflation fitting |
| US5087394A (en) * | 1989-11-09 | 1992-02-11 | Scimed Life Systems, Inc. | Method for forming an inflatable balloon for use in a catheter |
| ES2257791T3 (en) * | 1990-11-09 | 2006-08-01 | Boston Scientific Corporation | BALLOON FOR MEDICAL CATHETER. |
| US5195969A (en) | 1991-04-26 | 1993-03-23 | Boston Scientific Corporation | Co-extruded medical balloons and catheter using such balloons |
| US5330428A (en) * | 1991-05-14 | 1994-07-19 | Scimed Life Systems, Inc. | Dilatation catheter having a random copolymer balloon |
| JP3053029B2 (en) * | 1991-10-08 | 2000-06-19 | テルモ株式会社 | Vascular dilatation catheter balloon |
| US5344400A (en) * | 1992-04-06 | 1994-09-06 | Terumo Kabushiki Kaisha | Balloon catheters containing molded polyarylenesulfide material |
| US5348538A (en) * | 1992-09-29 | 1994-09-20 | Scimed Life Systems, Inc. | Shrinking balloon catheter having nonlinear or hybrid compliance curve |
| US5500180A (en) | 1992-09-30 | 1996-03-19 | C. R. Bard, Inc. | Method of making a distensible dilatation balloon using a block copolymer |
| US5338298A (en) * | 1993-06-04 | 1994-08-16 | C. R. Bard, Inc. | Double-tapered balloon |
| US6146356A (en) * | 1994-03-02 | 2000-11-14 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US6406457B1 (en) * | 1994-03-02 | 2002-06-18 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| DK0748232T4 (en) * | 1994-03-02 | 2009-01-19 | Boston Scient Scimed Inc | Catheter balloons of block copolymer elastomers |
| US6171278B1 (en) | 1994-03-02 | 2001-01-09 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US7163522B1 (en) | 1994-03-02 | 2007-01-16 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US5951941A (en) * | 1994-03-02 | 1999-09-14 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US5830182A (en) * | 1994-03-02 | 1998-11-03 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US7108826B2 (en) * | 1994-03-02 | 2006-09-19 | Boston Scientific Scimed, Inc. | High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions |
| ES2144574T3 (en) * | 1994-10-20 | 2000-06-16 | Interventional Technologies | PROCEDURE FOR THE MANUFACTURE OF A POLYMER MATERIAL WITH IMPROVED MECHANICAL PROPERTIES. |
| DE69633011T2 (en) | 1995-05-24 | 2004-12-09 | Schneider (Usa) Inc., Plymouth | POLYESTERETHERAMIDECOPOLYMER CONTAINING DILATION BALLOONS |
| US6273404B1 (en) | 1995-06-05 | 2001-08-14 | Scimed Life Systems, Inc. | Method of making monolithic hub and strain relief |
| US5645789A (en) * | 1995-07-20 | 1997-07-08 | Navius Corporation | Distensible pet balloon and method of manufacture |
| SE9600276D0 (en) * | 1996-01-25 | 1996-01-25 | Astra Ab | A wetting device for wetting a hydrophilic catheter and a urine collection bag incorporating said device |
| SE9602529D0 (en) * | 1996-06-26 | 1996-06-26 | Astra Ab | Medical device |
| US7749585B2 (en) * | 1996-10-08 | 2010-07-06 | Alan Zamore | Reduced profile medical balloon element |
| US20010008661A1 (en) | 1997-05-14 | 2001-07-19 | Eugene J. Jung Jr | Balloon for a dilation catheter and method for manufacturing a balloon |
| CA2232250C (en) | 1997-05-14 | 2007-06-26 | Navius Corporation | Balloon for a dilation catheter and method for manufacturing a balloon |
| US6358227B1 (en) | 1997-09-10 | 2002-03-19 | Scimed Life Systems, Inc. | Dilatation catheter balloon made from pen based homopolymer or random copolymer |
| US7101597B2 (en) | 1997-09-10 | 2006-09-05 | Boston Scientific Scimed, Inc. | Medical devices made from polymer blends containing low melting temperature liquid crystal polymers |
| US6242063B1 (en) | 1997-09-10 | 2001-06-05 | Scimed Life Systems, Inc. | Balloons made from liquid crystal polymer blends |
| US6284333B1 (en) | 1997-09-10 | 2001-09-04 | Scimed Life Systems, Inc. | Medical devices made from polymer blends containing low melting temperature liquid crystal polymers |
| US6176510B1 (en) * | 1997-11-19 | 2001-01-23 | Asahi Kasei Kogyo Kabushiki Kaisha | Air bag cover containing a block copolymer polypropylene resin blend |
| US6033413A (en) * | 1998-04-20 | 2000-03-07 | Endocare, Inc. | Stent delivery system |
| US6287506B1 (en) | 1998-07-09 | 2001-09-11 | Schneider (Usa) Inc. | Method for reducing dilation balloon cone stiffness |
| US6036697A (en) * | 1998-07-09 | 2000-03-14 | Scimed Life Systems, Inc. | Balloon catheter with balloon inflation at distal end of balloon |
| JP4883433B2 (en) * | 1999-05-16 | 2012-02-22 | 株式会社ワイエス・メディカル | Balloon catheter, method for manufacturing the same, and method for attaching balloon to catheter tube |
| US6500285B2 (en) | 1999-08-23 | 2002-12-31 | Scimed Life Systems, Inc. | Method of making a catheter having interlocking ribbed bond regions |
| US6592550B1 (en) | 1999-09-17 | 2003-07-15 | Cook Incorporated | Medical device including improved expandable balloon |
| US6977103B2 (en) * | 1999-10-25 | 2005-12-20 | Boston Scientific Scimed, Inc. | Dimensionally stable balloons |
| US6575959B1 (en) | 1999-12-27 | 2003-06-10 | Scimed Life Systems, Inc. | Catheter incorporating an insert molded hub and method of manufacturing |
| US6881209B2 (en) | 2000-05-25 | 2005-04-19 | Cook Incorporated | Medical device including unitary, continuous portion of varying durometer |
| US6673302B2 (en) * | 2001-01-24 | 2004-01-06 | Scimed Life Systems, Inc. | Wet processing method for catheter balloons |
| DE10145633A1 (en) * | 2001-09-15 | 2003-04-10 | Peter Hochmuth | Sports glove with outer coating on the palm |
| US7214220B2 (en) * | 2001-09-21 | 2007-05-08 | Boston Scientific Scimed, Inc. | Intravascular device with carrier tube engagement member |
| US7625365B2 (en) * | 2001-09-21 | 2009-12-01 | Boston Scientific Scimed, Inc. | Intravascular device and carrier tube with interference fit member |
| US6730377B2 (en) | 2002-01-23 | 2004-05-04 | Scimed Life Systems, Inc. | Balloons made from liquid crystal polymer blends |
| US6946173B2 (en) * | 2002-03-21 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Catheter balloon formed of ePTFE and a diene polymer |
| US9017308B2 (en) | 2002-05-21 | 2015-04-28 | Boston Scientific Scimed, Inc. | Insert molded hub and strain relief |
| US8003725B2 (en) | 2002-08-12 | 2011-08-23 | Exxonmobil Chemical Patents Inc. | Plasticized hetero-phase polyolefin blends |
| EP1530611B1 (en) | 2002-08-12 | 2013-12-04 | ExxonMobil Chemical Patents Inc. | Plasticized polyolefin compositions |
| US7998579B2 (en) | 2002-08-12 | 2011-08-16 | Exxonmobil Chemical Patents Inc. | Polypropylene based fibers and nonwovens |
| US7531594B2 (en) | 2002-08-12 | 2009-05-12 | Exxonmobil Chemical Patents Inc. | Articles from plasticized polyolefin compositions |
| US7271209B2 (en) | 2002-08-12 | 2007-09-18 | Exxonmobil Chemical Patents Inc. | Fibers and nonwovens from plasticized polyolefin compositions |
| US7652092B2 (en) * | 2002-08-12 | 2010-01-26 | Exxonmobil Chemical Patents Inc. | Articles from plasticized thermoplastic polyolefin compositions |
| US7652094B2 (en) * | 2002-08-12 | 2010-01-26 | Exxonmobil Chemical Patents Inc. | Plasticized polyolefin compositions |
| US7622523B2 (en) * | 2002-08-12 | 2009-11-24 | Exxonmobil Chemical Patents Inc. | Plasticized polyolefin compositions |
| US7763043B2 (en) * | 2003-01-09 | 2010-07-27 | Boston Scientific Scimed, Inc. | Dilatation catheter with enhanced distal end for crossing occluded lesions |
| WO2004091471A2 (en) * | 2003-04-04 | 2004-10-28 | Berger, Constance, F. | Apparatus for heating bottles and method of manufacturing same |
| US8192813B2 (en) | 2003-08-12 | 2012-06-05 | Exxonmobil Chemical Patents, Inc. | Crosslinked polyethylene articles and processes to produce same |
| US8012144B2 (en) * | 2003-09-22 | 2011-09-06 | Boston Scientific Scimed, Inc. | Elongate medical device having an interference fit packaging member |
| WO2005080495A1 (en) * | 2004-02-12 | 2005-09-01 | Exxonmobil Chemical Patents Inc. | Plasticized polyolefin compositions |
| US20050234499A1 (en) * | 2004-04-19 | 2005-10-20 | Scimed Life Systems, Inc. | Multi-lumen balloon catheter including manifold |
| US7662144B2 (en) | 2004-06-22 | 2010-02-16 | Boston Scientific Scimed, Inc. | Catheter shaft with improved manifold bond |
| US8389615B2 (en) | 2004-12-17 | 2013-03-05 | Exxonmobil Chemical Patents Inc. | Elastomeric compositions comprising vinylaromatic block copolymer, polypropylene, plastomer, and low molecular weight polyolefin |
| JP5438966B2 (en) | 2005-07-15 | 2014-03-12 | エクソンモービル・ケミカル・パテンツ・インク | Elastomer composition |
| JP2010051631A (en) * | 2008-08-29 | 2010-03-11 | Nippon Sherwood Medical Industries Ltd | Medical multilayer tube |
| JP2010063648A (en) * | 2008-09-11 | 2010-03-25 | Nippon Sherwood Medical Industries Ltd | Distal-end flexible medical tube |
| US8287890B2 (en) * | 2009-12-15 | 2012-10-16 | C.R. Bard, Inc. | Hydrophilic coating |
| WO2013059204A1 (en) | 2011-10-21 | 2013-04-25 | Boston Scientific Scimed, Inc. | Locking catheter hub |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA904138A (en) * | 1972-07-04 | L. Gagne Joseph | Catheter and method of making same | |
| US3503399A (en) * | 1967-02-06 | 1970-03-31 | Brunswick Corp | Retention catheter with balloon secured thereto by an adhesive preventing plasticizer migration |
| US3528869A (en) * | 1968-02-28 | 1970-09-15 | Davol Inc | Manufacture of plastic catheter |
| GB1234037A (en) * | 1968-05-22 | 1971-06-03 | ||
| GB1313347A (en) * | 1970-07-02 | 1973-04-11 | Davol Inc | Method of manufacturing a balloon catheter |
| JPS5228314B2 (en) * | 1973-07-16 | 1977-07-26 | ||
| US3889685A (en) * | 1973-11-02 | 1975-06-17 | Cutter Lab | Tubular unit with vessel engaging cuff structure |
| JPS5821651B2 (en) * | 1973-11-19 | 1983-05-02 | ハイ ボルテ−ジ エンジニアリング コ−ポレ−シヨン | catheter |
| CS173836B1 (en) * | 1974-03-19 | 1977-03-31 | ||
| US3926705A (en) * | 1974-07-25 | 1975-12-16 | Western Acadia | Silicone catheter and process for manufacturing same |
| US3982544A (en) * | 1974-11-18 | 1976-09-28 | Johnson & Johnson | Device for everting a probe into a body cavity |
-
1977
- 1977-11-21 US US05/853,738 patent/US4154244A/en not_active Expired - Lifetime
-
1978
- 1978-11-16 CA CA000316346A patent/CA1155578A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4154244A (en) | 1979-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1155578A (en) | Thermoplastic elastomeric block copolymer balloon-type catheters | |
| US4198983A (en) | Catheter made of a thermoplastic material having improved softness and low friction | |
| US4481323A (en) | Hydrocarbon block copolymer with dispersed polysiloxane | |
| US4511354A (en) | Hydrocarbon block copolymer with dispersed polysiloxane | |
| US4386179A (en) | Hydrocarbon block copolymer with dispersed polysiloxane | |
| EP1307509B1 (en) | Kink resistant medical tubes | |
| US4335723A (en) | Catheter having inflatable retention means | |
| US4196731A (en) | Silicone-containing thermoplastic polymers for medical uses | |
| US4117035A (en) | Blend of thermoplastic polymers including block radial polymers of the butadiene-styrene type | |
| EP1252909B1 (en) | A pilot balloon for balloon catheters | |
| US4048255A (en) | Blend of thermoelastic polymers with block radial polymers used as pharmaceutical sealing and resealing materials | |
| US4327726A (en) | Connector member for dissimilar materials | |
| US8633268B2 (en) | Synthetic polyisoprene foley catheter | |
| EP1275891A1 (en) | Multilayered tube and medical supply comprising multilayered tube | |
| JPS5974153A (en) | Resin composition | |
| US4698059A (en) | Enteral feeding tubes | |
| JPH0625505A (en) | Elastomer article and liquid elastomer solution | |
| JPS62161380A (en) | Catheter assembly | |
| DE2848854A1 (en) | CATHETERS, ESPECIALLY BALLOON CATHETERS, AND PLASTIC DIMENSIONS FOR ITS PRODUCTION | |
| US4552914A (en) | Hydrocarbon block copolymer with dispersed polysiloxane | |
| JP2002248671A (en) | Endotracheal tube | |
| JP4819263B2 (en) | Thermoplastic resin composition | |
| GB2108971A (en) | Thermoplastic elastomeric compositions and inflatable cuffs formed therefrom | |
| GB2150935A (en) | Enteral feeding tubes or boluses made from elastomeric polymeric composition | |
| JPS6026508B2 (en) | Hydrocarbon block copolymer containing dispersed polysiloxane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |